Effects of several inhibitors on the K+ efflux induced by activation of the Ca2+-dependent channel and by valinomycin in the human red cell.
D000968:Antimycin A / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002712:Chlorides / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D009840:Oligomycins / Q000494:pharmacology; D011188:Potassium / Q000037:antagonists & inhibitors / Q000097:blood*; D011433:Propranolol / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism; D014634:Valinomycin / Q000494:pharmacology*
D002712:Chlorides; D007473:Ion Channels; D009840:Oligomycins; D014634:Valinomycin; D000001:Calcimycin; D000968:Antimycin A; D004176:Dipyridamole; D012964:Sodium; D011433:Propranolol; D011796:Quinacrine; D011188:Potassium; D002746:Chlorpromazine